NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc. (NBGV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nbgv · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
NewBridge Global Ventures, Inc.You NBGV | $1M | N/A | — | — |
 Claritas Pharmaceuticals, Inc. CLAZF | $0M | 0.00x | -98.3% | $0.16 |
 China BCT Pharmacy Group, Inc. CNBI | $1M | 0.36x | +98.3% | $0.55 |
 American Caresource Holdings, Inc. GNOW | $1M | N/A | — | -$1.78 |
 Laxai Pharma, Ltd. LAXAF | $0M | N/A | — | — |
 Lotus Ventures Inc. LTTSF | $0M | N/A | — | -$0.02 |
 Point of Care Nano-Technology, Inc. PCNT | $1M | N/A | — | -$0.10 |
Industry Average 2 peers with valid PE | — | 0.18x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for NewBridge Global Ventures, Inc. (NBGV) measures how much investors pay for each dollar of the company's trailing earnings. NBGV's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of —.
Frequently asked questions
NBGV pe ratio · 6 questionsNBGV's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via NBGV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NewBridge Global Ventures, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09